Form D · Other
Innovation1 Biotech Inc.
Rockaway, NJ · CIK 0001629205
Offering snapshot reported Apr 24, 2023 · SEC filing
- Reported sold
- $187K Offering amount: $280K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $93.3K Reported outside-investor minimum
- First sale
- Apr 13, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 24, 2023 | Initial | $186,666 | No comparison | 2 | SEC filing |
| Dec 27, 2022 | Initial | $300,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-479752
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Apr 24, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frederick E. Pierce | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
179 Rte 46 W Suite 15 #147
Rockaway, NJ, 07866
Rockaway, NJ, 07866